Impact of Daily Prophylaxis Dose Anticoagulation with a Factor Xa Inhibitor (Apixaban) in Patients with Sickle Cell Disease
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Bristol-Myers Squibb
Start Date
December 1, 2013
End Date
November 30, 2016
Administered By
Medicine, Hematology
Awarded By
Bristol-Myers Squibb
Start Date
December 1, 2013
End Date
November 30, 2016